Amphetamine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Study to Evaluate the Abuse Liability, Pharmacokinetics, Safety and Tolerability of an Abuse-Deterrent d-Amphetamine Sulfate Immediate Release Formulation (ADAIR)
Conditions:   ADHD;   Narcolepsy Interventions:   Drug: ADAIR 10 mg IR tablets;   Drug: d-amphetamine sulfate;   Drug: Placebo Sponsor:   Vallon Pharmaceuticals, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2020 Category: Research Source Type: clinical trials